Maternal hormone levels and risk of cryptorchism among populations at high and low risk of testicular germ cell tumors

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 7, 2005, Pages 1732-1737

  McGlynn, Katherine A ^a   Graubard, Barry I ^a   Nam, Jun Mo ^a   Stanczyk, Frank Z ^c   Longnecker, Matthew P ^d   Klebanoff, Mark A ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ESTRADIOL; ESTRIOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD SAMPLING; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; CRYPTORCHISM; ESTROGEN BLOOD LEVEL; GERM CELL TUMOR; HIGH RISK POPULATION; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL BLOOD; PREGNANCY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; TESTIS TUMOR; THIRD TRIMESTER PREGNANCY;

ADULT; COHORT STUDIES; CRYPTORCHIDISM; FEMALE; GERMINOMA; GONADAL STEROID HORMONES; HUMANS; INFANT, NEWBORN; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; RISK; TESTICULAR NEOPLASMS;

EID: 22244478600     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0128     Document Type: Article

References (37)

1. Scorer CG. The descent of the testis. Arch Dis Child 1964;39:605-9.
2. Chilvers C, Dudley NE, Gough MH, Jackson MB, Pike MC. Undescended testis: the effect of treatment on subsequent risk of subfertility and malignancy. J Pediatr Surg 1986;21:691-6.
3. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001;16:972-8.
4. Henderson BE, Ross RK, Pike MC, Depue RH. Epidemiology of testis cancer. In: Skinner D, editor. Urological cancer. New York: Grune & Stratton; 1983. p. 237.
5. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993;341: 1392-5.
6. Burton MH, Davies TW, Raggatt PR. Undescended testis and hormone levels in early pregnancy. J Epidemiol Community Health 1987;41:127-9.
7. Bernstein L, Pike MC, Depue RH, Ross RK, Moore JW, Henderson BE. Maternal hormone levels in early gestation of cryptorchid males: a case-control study. Br J Cancer 1988;58:379-81.
8. Key TJ, Bull D, Ansell P, et al. A case-control study of cryptorchidism and maternal hormone concentrations in early pregnancy. Br J Cancer 1996;73: 698-701.
9. McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 2003;97:63-70.
10. Henderson BE, Bernstein L, Ross RK, Depue RH, Judd HL. The early in utero oestrogen and testosterone environment of Blacks and Whites: potential effects on male offspring. Br J Cancer 1988;57:216-8.
11. Richardson BE, Hulka BS, Peck JL, et al. Levels of maternal serum α-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk. Am J Epidemiol 1998;148:719-27.
12. Melbye M, Wohlfahrt J, Lei U, et al. α-Fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence. J Natl Cancer Inst 2000;92:1001-5.
13. Lambe M, Trichopoulos D, Hsieh CC, Wuu J, Adami HO, Wide L. Ethnic differences in breast cancer risk: a possible role for pregnancy levels of α-fetoprotein? Epidemiology 2003;14:85-9.
14. Niswander KR, Gordon M. The women and their pregnancies. Washington, DC: U.S. Government Printing Office, U.S. Department of Health, Education, and Welfare. NIH Pub No. 73-379; 1972.
15. Hutson JM, Hasthorpe S, Heyns CF. Anatomical and functional aspects of testicular descent and cryptorchism. J Urol 1997;18:259-80.
16. Myrianthopoulos NC, French KS. An application of the U.S. Bureau of the Census socioeconomic index to a large, diversified patient population. Soc Sci Med 1968;2:283-99.
17. Katagiri H, Stanczyk FZ, Goebelsmann U. Estriol in pregnancy. III. Development, comparison and use of specific antisera for rapid radioimmunoassay of unconjugated estriol in pregnancy plasma. Steroids 1974; 24:225-38.
18. Goebelsmann U, Bernstein GS, Gale JA, et al. Serum gonadotropin, testosterone, estradiol and estrone levels prior to and following bilateral vasectomy. In: Lepow IH, Crozier R, editors. Vasectomy: immunologic and pathophysiologic effects in animals and man. New York: Academic Press; 1979. p. 165.
19. Sodergard R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J Steroid Biochem 1982;16:801-10.
20. Sharpe RM. The "oestrogen hypothesis"-where do we stand now? Int J Androl 2003;26:2-15.
21. Troisi R, Potischman N, Roberts J, et al. Associations of maternal and umbilical cord hormone concentrations with maternal, gestational and neonatal factors (United States). Cancer Causes Control 2003;14: 347-55.
22. Zhang Y, Graubard BI, Klebanoff MA, et al. Maternal hormone levels among populations at high and low risk of testicular germ cell cancer. Br J Cancer 2005;92:1787-93.
23. Lipworth L, Hsieh CC, Wide L, et al. Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer 1999;79:7-12.
24. Scorer CG, Farrington GH. Congenital deformities of the testis and epididymis. New York: Appleton-Century-Crofts; 1971. p. 18-27.
25. Vatten LJ, Romundstad PR, Odegard RA, Nilsen ST, Trichopoulos D, Austgulen R. α-foetoprotein in umbilical cord in relation to severe pre-eclampsia, birth weight and future breast cancer risk. Br J Cancer 2002;86: 728-31.
26. Jacobson HI, Thompson WD, Janerich DT. Multiple births and maternal risk of breast cancer. Am J Epidemiol 1989;129:865-73.
27. Vatten LJ, Romundstad PR, Trichopoulos D, Skjaerven R. Pre-eclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer 2002;87: 971-3.
28. Lambe M, Hsieh C, Tsaih S, Ekbom A, Adami HO, Trichopoulos D. Maternal risk of breast cancer following multiple births: a nationwide study in Sweden. Cancer Causes Control 1996;7:533-8.
29. Braum MM, Ahlbom A, Floderus B, Brinton LA, Hoover RN. Effect of twinship on incidence of cancer of the testis, breast, and other sites (Sweden). Cancer Causes Control 1995;6:519-24.
30. Aschim EL, Haugen TB, Tretli S, Daltveit AK, Grotmol T. Risk factors for hypospadias in Norwegian boys-association with testicular dysgenesis syndrome? Int J Androl 2004;27:213-21.
31. Davies TW, Williams DR, Whitaker RH. Risk factors for undescended testis. Int J Epidemiol 1986;15:197-201.
32. Hjertkvist M, Damber JE, Bergh A. Cryptorchidism: a registry based study in Sweden on some factors of possible aetiological importance. J Epidemiol Community Health 1989;43:324-9.
33. Jones ME, Swerdlow AJ, Griffith M, Goldacre MJ. Prenatal risk factors for cryptorchidism: a record linkage study. Paediatr Perinat Epidemiol 1998;12: 383-96.
34. Biggs ML, Baer A, Critchlow CW. Maternal, delivery, and perinatal characteristics associated with cryptorchidism: a population-based case-control study among births in Washington State. Epidemiology 2002;13:197-204.
35. Akre O, Lipworth L, Cnattingius S, Sparen P, Ekbom A. Risk factor patterns for cryptorchidism and hypospadias. Epidemiology 1999;10:364-9.
36. Troisi R, Potischman N, Roberts JM, et al. Correlation of serum hormone concentrations in maternal and umbilical cord samples. Cancer Epidemiol Biomarkers Prev 2003;12:452-6.
37. van de Beek C, Thijssen JH, Cohen-Kettenis PT, van Goozen SH, Buitelaar JK. Relationships between sex hormones assessed in amniotic fluid, and maternal and umbilical cord serum: what is the best source of information to investigate the effects of fetal hormonal exposure? Horm Behav 2004;46:663-9.